Cinzia Bizzarri

2.3k total citations
34 papers, 1.5k citations indexed

About

Cinzia Bizzarri is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Cinzia Bizzarri has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 15 papers in Immunology. Recurrent topics in Cinzia Bizzarri's work include Chemokine receptors and signaling (12 papers), Immune Response and Inflammation (9 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Cinzia Bizzarri is often cited by papers focused on Chemokine receptors and signaling (12 papers), Immune Response and Inflammation (9 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). Cinzia Bizzarri collaborates with scholars based in Italy, United States and Sweden. Cinzia Bizzarri's co-authors include Riccardo Bertini, Marcello Allegretti, Andrea R. Beccari, Francesco Colotta, Gianfranco Caselli, Roberto Civitelli, Rosa Di Bitondo, Massimo Locati, Pietro Ghezzi and Sabrina Pagliei and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Cinzia Bizzarri

34 papers receiving 1.5k citations

Peers

Countries citing papers authored by Cinzia Bizzarri

Since Specialization

Citations

This map shows the geographic impact of Cinzia Bizzarri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinzia Bizzarri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinzia Bizzarri more than expected).

Fields of papers citing papers by Cinzia Bizzarri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinzia Bizzarri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinzia Bizzarri. The network helps show where Cinzia Bizzarri may publish in the future.

Co-authorship network of co-authors of Cinzia Bizzarri

This figure shows the co-authorship network connecting the top 25 collaborators of Cinzia Bizzarri. A scholar is included among the top collaborators of Cinzia Bizzarri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinzia Bizzarri. Cinzia Bizzarri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non‐competitive allosteric inhibitor 2011 ·British Journal of Pharmacology ·Riccardo Bertini, Lucíola S. Barcelos, (unknown), Barbara Cavalieri, Alessio Moriconi, Cinzia Bizzarri, Paola Di Benedetto, Claudia Di Giacinto, Isabelle Gloaguen, Emanuela Galliera, Massimiliano Marco Corsi Romanelli, Remo Castro Russo, Sílvia Passos Andrade, (unknown), Giuseppe Nano, Andrea Aramini, Juan Carlos Cutrìn, Massimo Locati, Marcello Allegretti, Mauro Martins Teixeira	57
2	Structure–Activity Relationship of novel phenylacetic CXCR1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Maria Candida Cesta, Alessio Moriconi, Andrea Aramini, Cinzia Bizzarri, Claudia Di Giacinto, Rosa Di Bitondo, Isabelle Gloaguen, Massimiliano Aschi, Marcello Crucianelli, Riccardo Bertini, Marcello Allegretti	6
3	Allosteric inhibitors of chemoattractant receptors: opportunities and pitfalls 2008 ·Trends in Pharmacological Sciences ·Marcello Allegretti, Riccardo Bertini, Cinzia Bizzarri, Andrea R. Beccari, Alberto Mantovani, Massimo Locati	23
4	Blockade of the chemokine receptor CXCR2 ameliorates adjuvant‐induced arthritis in rats 2007 ·British Journal of Pharmacology ·Michele M. Barsante, Thiago M. Cunha, Marcello Allegretti, (unknown), (unknown), Cinzia Bizzarri, Wagner Luiz Tafuri, Stephen Poole, Fernando Q. Cunha, Riccardo Bertini, Mauro Martins Teixeira	72
5	Development of a systemically-active dual CXCR1/CXCR2 allosteric inhibitor and its efficacy in a model of transient cerebral ischemia in the rat 2006 ·CINECA IRIS Institutional Research information system (University of Urbino) ·(unknown), Riccardo Bertini, (unknown), Cinzia Bizzarri, Roberto Anacardio, (unknown), Marcello Allegretti, Pietro Ghezzi, Pia Villa	32
6	ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets 2006 ·Pharmacology & Therapeutics ·Cinzia Bizzarri, Andrea R. Beccari, Riccardo Bertini, (unknown), (unknown), Marcello Allegretti	172
7	Targeting C5a: Recent Advances in Drug Discovery 2005 ·Current Medicinal Chemistry ·Marcello Allegretti, Alessio Moriconi, Andrea R. Beccari, Rosa Di Bitondo, Cinzia Bizzarri, Riccardo Bertini, Francesco Colotta	63
8	Requirements for the Different Cysteines in the Chemotactic and Desensitizing Activity of Human Thioredoxin 2005 ·Antioxidants and Redox Signaling ·Cinzia Bizzarri, Arne Holmgren, Klas Pekkari, (unknown), Francesco Colotta, Pietro Ghezzi, Riccardo Bertini	22
9	Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2 2004 ·Biochemical Pharmacology ·(unknown), Andrea Bianchini, Isabelle Gloaguen, Leda Biordi, Edoardo Alesse, Claudio Festuccia, Barbara Cavalieri, Raffaele Strippoli, Maria Neve Cervellera, Rosa Di Bitondo, Elisabetta Ferretti, Fabrizio Mainiero, Cinzia Bizzarri, Francesco Colotta, Riccardo Bertini	90
10	Selective inhibition of interleukin-8-induced neutrophil chemotaxis by ketoprofen isomers 11Abbreviations: NSAIDs, non-steroidal anti-inflammatorydrugs; COX, cyclooxygenase; PG, prostaglandin; PMN, humanpolymorphonuclear leukocyte; IL-8, interleukin-8;[Ca2+]i, intracellular calcium concentration;MAPK, mitogen-activated protein kinases; fMLP,N-formyl-methionyl-leucyl-phenylalanine; ERK, extracellular signalregulated kinase; C5a, fifth component of complement; MCP-1, monocytechemotactic protein-1; NAP-2, neutrophil activating protein-2; GCP-2,granulocyte chemotactic peptide-2; PVP, polyvinylpyrrolidone; HBSS,Hank’s balanced salt solution; ENA-78, epithelial-derived neutrophilactivating protein-78; ECL, enhanced chemiluminescent; FURA-2AM;1-[2-(5-carboxyoxazol-2-yl)-6-amino-benzofuran-5-oxy]-2-(2′-amino-5′-ethlphenoxy)-ethane-N,N,N′,N′-tetraaceticacid pentaacetoxy methylester; MGSA/GRO, melanoma growth stimulatoryactivity/gene product of gro gene. 2001 ·Biochemical Pharmacology ·Cinzia Bizzarri, Sabrina Pagliei, Laura Brandolini, (unknown), Gianfranco Caselli, Pietro Transidico, Silvano Sozzani, Riccardo Bertini	32
11	Purification of Human Recombinant Interleukin 1 Receptor Antagonist Proteins uponBacillus subtilisSporulation 1997 ·Protein Expression and Purification ·(unknown), Vito Di Cioccio, Giovanni Macchia, Paola Bossù, Cinzia Bizzarri, (unknown), Diana Boraschi, Aldo Tagliabue, Paolo Ruggiero	9
12	Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II 1997 ·The Journal of Immunology ·Paolo Ruggiero, Paola Bossù, G Macchia, (unknown), (unknown), Riccardo Bertini, (unknown), Cinzia Bizzarri, (unknown), Vito Di Cioccio, Gabriele D’Andrea, A. Di Giulio, Francesco Frigerio, Renata Grifantini, Guido Grandi, Aldo Tagliabue, Diana Boraschi	13
13	Interaction between interleukin-1 and ciliary neurotrophic factor in the regulation of neuroblastoma cell functions. 1997 ·PubMed ·Paola Bossù, Paolo Ruggiero, Gabriella Macchia, (unknown), Cinzia Bizzarri, Drorit Neumann, Aldo Tagliabue, Diana Boraschi	4
14	Mapping of receptor binding sites on IL-1 β by reconstruction of IL-1ra-like domains 1995 ·The Journal of Immunology ·Diana Boraschi, Paola Bossù, Paolo Ruggiero, Aldo Tagliabue, Riccardo Bertini, G Macchia, (unknown), (unknown), G. Melillo, (unknown), (unknown), Cinzia Bizzarri, (unknown), Andrew R. Mackay, Gianni Frascotti, Francesco Frigerio, Renata Grifantini, Guido Grandi	20
15	Norepinephrine, unlike ATP, induces all‐or‐none increase in cytosolic calcium in thyroid cells 1994 ·European Journal of Biochemistry ·Cinzia Bizzarri, Daniela Corda	11
16	Ligand binding to monocyte alpha 5 beta 1 integrin activates the alpha 2 beta 1 receptor via the alpha 5 subunit cytoplasmic domain and protein kinase C. 1994 ·The Journal of Immunology ·Robert E. Pacifici, Janet Roman, Robert B. Kimble, Roberto Civitelli, (unknown), Cinzia Bizzarri	70
17	Activation of the Ca2+ message system by parathyroid hormone is dependent on the cell cycle 1994 ·Endocrinology ·Cinzia Bizzarri	4
18	Muscarinic regulation of phospholipase A2 and iodide fluxes in FRTL-5 thyroid cells 1991 ·European Journal of Endocrinology ·Maria Di Girolamo, Daniela D’Arcangelo, Cinzia Bizzarri, Daniela Corda	19
19	Evidence that a guanine nucleotide-binding protein linked to a muscarinic receptor inhibits directly phospholipase C. 1990 ·Proceedings of the National Academy of Sciences ·Cinzia Bizzarri, Maria Di Girolamo, Michele D’Orazio, Daniela Corda	36
20	G Protein-Linked Receptors in the Thyroid 1989 ·Advances in experimental medicine and biology ·Daniela Corda, Cinzia Bizzarri, Maria Di Girolamo, Salvatore Valitutti, Alberto Luini	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact